Wolverine Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$422K Buy
+6,259
New +$417K ﹤0.01% 980
2025
Q3
Sell
-1,572
Closed -$124K 1660
2025
Q2
$137K Buy
+1,572
New +$123K ﹤0.01% 1076
2023
Q4
Sell
-2,400
Closed -$224K 1839
2023
Q3
$224K Buy
+2,400
New +$271K ﹤0.01% 1037
2020
Q3
Sell
-16
Closed -$1.67K 1592
2020
Q2
$1K Sell
16
-1,428
-99% -$128K ﹤0.01% 1489
2020
Q1
$97K Buy
+1,444
New +$89.9K ﹤0.01% 1051
2019
Q1
Sell
-53,564
Closed -$1.88M 1451
2018
Q4
$1.6M Buy
+53,564
New +$1.7M 0.02% 629
2017
Q3
Sell
-17,600
Closed -$321K 1365
2017
Q2
$321K Buy
+17,600
New +$325K ﹤0.01% 875

Other funds holding DXCM

Wolverine Asset Management's DXCM Position: Q2 2026 in Review

Wolverine Asset Management opened a new position in DexCom (DXCM) in Q2 2026: 6,259 shares worth $422K. The stake represents ﹤0.01% of the portfolio and ranks #980 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in DXCM as recently as Q2 2025.

Wolverine Asset Management first reported a position in DXCM in Q2 2017 and has held it in 7 quarters since. The position peaked at $1.6M in Q4 2018. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Wolverine Asset Management held 6,259 shares of DexCom worth $422K as of Q2 2026.
  • DexCom was a new Wolverine Asset Management position in Q2 2026.
  • DexCom made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #980 holding.
  • Wolverine Asset Management first reported a position in DexCom in Q2 2017 and has held it in 7 quarters since.
  • Wolverine Asset Management's DexCom position peaked at $1.6M in Q4 2018.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.